Biblio | Department of Radiology

Found 19 results

Filters: Keyword is Apolipoproteins E [Clear All Filters]

2022

Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJelle, Aarsland D, Alcolea D, Altomare D, von Arnim C et al.. 2022. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.. JAMA Neurol. 79(3):228-243.

2020

Rahman A, Schelbaum E, Hoffman K, Diaz I, Hristov H, Andrews R, Jett S, Jackson H, Lee A, Sarva H et al.. 2020. Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.. Neurology. 95(2):e166-e178.

2019

Goudey B, Fung BJ, Schieber C, Faux NG. 2019. A blood-based signature of cerebrospinal fluid Aβ status.. Sci Rep. 9(1):4163.

Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP et al.. 2019. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.. Sci Transl Med. 11(506)

Zhou X, Chen Y, Mok KY, C Y Kwok T, Mok VCT, Guo Q, Ip FC, Chen Y, Mullapudi N, Giusti-Rodríguez P et al.. 2019. Non-coding variability at the APOE locus contributes to the Alzheimer's risk.. Nat Commun. 10(1):3310.

2017

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al.. 2017. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.

2015

Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S et al.. 2015. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.. Brain. 138(Pt 9):2701-15.

2014

Duits FH, Teunissen CE, Bouwman FH, Visser P-J, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N et al.. 2014. The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 10(6):713-723.e2.

2013

Randall C, Mosconi L, de Leon M, Glodzik L. 2013. Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.. Front Biosci (Landmark Ed). 18(3):1150-73.

2009

Glodzik-Sobanska L, Pirraglia E, Brys M, de Santi S, Mosconi L, Rich KE, Switalski R, Louis LSaint, Sadowski MJ, Martiniuk F et al.. 2009. The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.. Neurobiol Aging. 30(5):672-81.

2007

Mosconi L, Brys M, Glodzik-Sobanska L, de Santi S, Rusinek H, de Leon MJ. 2007. Early detection of Alzheimer's disease using neuroimaging.. Exp Gerontol. 42(1-2):129-38.

de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Louis LASaint, Sobanska L et al.. 2007. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.. Ann N Y Acad Sci. 1097:114-45.

Jaffer FA, Kim D-E, Quinti L, Tung C-H, Aikawa E, Pande AN, Kohler RH, Shi G-P, Libby P, Weissleder R. 2007. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.. Circulation. 115(17):2292-8.

2006

Deguchi J-o, Aikawa M, Tung C-H, Aikawa E, Kim D-E, Ntziachristos V, Weissleder R, Libby P. 2006. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.. Circulation. 114(1):55-62.

2005

2002

Chen J, Tung C-H, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R. 2002. In vivo imaging of proteolytic activity in atherosclerosis.. Circulation. 105(23):2766-71.

2001

de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, Tsui W, Kandil E, Scherer AJ, Roche A et al.. 2001. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).. Proc Natl Acad Sci U S A. 98(19):10966-71.

1998

Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A, Osborne D, Weaver A et al.. 1998. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.. Ann Neurol. 44(2):288-91.